Dipyridamole and Adcirca drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dipyridamole (dipyridamole) and Adcirca (tadalafil). Common drug interactions include nausea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Dipyridamole and Adcirca. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Dipyridamole?

Dipyridamole has active ingredients of dipyridamole. eHealthMe is studying from 5,998 Dipyridamole users. Check the latest studies of Dipyridamole.

What is Adcirca?

Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.

On Jul, 17, 2026

29 people who take Dipyridamole and Adcirca together, and have interactions are studied.

Dipyridamole and Adcirca drug interactions.

What are the common drug interactions of Dipyridamole and Adcirca, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Diarrhoea
Headache (pain in head)
Hypokalaemia (low potassium)
Dyspnoea (difficult or laboured respiration)
Hot flush (sudden feelings of heat)
Pain in jaw
Pericardial effusion (fluid around the heart)
Flushing (the warm, red condition of human skin)
Heart rate increased

male:

Diarrhoea
Abdominal distension
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Pyrexia (fever)
Injection site pruritus (severe itching at injection site)
Lymphadenopathy (disease or enlargement of lymph nodes)
Nausea (feeling of having an urge to vomit)
Catheter site swelling
Infection
Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)

What are the common drug interactions of Dipyridamole and Adcirca, by age (0-1 to 60+)? *:

0-1:

Diarrhoea
Asthma
Atelectasis (partial or complete collapse of the lung)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
C-reactive protein increased
Oxygen saturation decreased
Pneumonia
Pyrexia (fever)
Injection site pruritus (severe itching at injection site)
Lymphadenopathy (disease or enlargement of lymph nodes)

2-9:

n/a

10-19:

Nausea (feeling of having an urge to vomit)
Headache (pain in head)
Pulmonary arterial pressure increased

20-29:

Diarrhoea
Nausea (feeling of having an urge to vomit)
Headache (pain in head)
Hot flush (sudden feelings of heat)
Hypokalaemia (low potassium)
Pain in jaw
Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Heart rate increased
Inflammation

30-39:

Ascites (accumulation of fluid in the abdominal cavity)
Hypotension (abnormally low blood pressure)
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Abdominal distension

40-49:

Death
Pneumonia
Pyrexia (fever)

50-59:

n/a

60+:

Dyspnoea (difficult or laboured respiration)
Weight increased
Death
Lung carcinoma cell type unspecified stage iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver)
Lung neoplasm malignant (cancer tumour of lung)
Weight decreased

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 22 people, 75.86%
Right Ventricular Failure (right half of the heart fails to work): 6 people, 20.69%
Diarrhea: 5 people, 17.24%
Mixed Connective Tissue Disease (an autoimmune disease, in which the body's defence system attacks itself): 4 people, 13.79%
Hypokalemia (low potassium): 4 people, 13.79%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 4 people, 13.79%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 13.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.79%
Chronic Infantile Neurological Cutaneous And Articular Syndrome (a rare genetic periodic fever with joints inflammation): 4 people, 13.79%
Transposition Of The Great Vessels: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Dipyridamole and Adcirca?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously